SPECTRANETICS LEAD LOCKING DEVICE 518-062

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,foreign,health pr report with the FDA on 2020-02-10 for SPECTRANETICS LEAD LOCKING DEVICE 518-062 manufactured by The Spectranetics Corporation.

Event Text Entries

[178573281] Patient's weight unavailable. Device lot number, expiration date unavailable. Device manufacture date unavailable.
Patient Sequence No: 1, Text Type: N, H10


[178573282] A lead extraction procedure commenced to remove three leads: a right atrial (ra) lead, a right ventricular (rv) lead and a left ventricular (lv) lead due to infection. Spectranetics lead locking devices (lld's) were present in each lead. The physician used a 14f glidelight laser sheath and progressed to the top half of the superior vena cava coil of the lead, when the coil started to stretch and unwind. The physician then chose to attempt extraction of the ra lead, which was successful with no complications. The physician then targeted the lv lead. The physician was able to advance to the mouth of the coronary sinus (cs). The tip of this lead appeared to still be attached, however, using very little force the tip suddenly came free and the lead was extracted successfully. The patient was stable and the physician continued. The physician proceeded to extract the rv lead again and due to the appearance of a "snowplow" affect on the lead, the physician chose to upsize to a 16f glidelight device to reduce force on the rv lead. As the physician was beginning to use the 16f glidelight device, anesthetist noted a rapid drop in the patient''s vital signs. At this point, the cardiac surgeon who was in the room confirmed with the physician to continue removal of the rv lead, which was successful. Rescue efforts began, including rescue device, cpr and sternotomy. A tear at the back of the heart (coronary sinus) was identified and the patient was prepared to be placed on bypass. The surgeon attempted to occlude the hole and administer hand compressions to the heart to circulate blood through the patient? S body. Once the patient was on bypass, repair to the injury began and was successful. Continued interventions were in place, including attempts to remove the patient from the bypass machine. The patient was placed on peripheral ecmo until the patient's heart was strong enough to function on its own. The patient survived the procedure. This report is being submitted to capture the lld which was present in the lv lead (within the cs, the area of injury) as the traction platform to aid in lead removal.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1721279-2020-00033
MDR Report Key9687222
Report SourceDISTRIBUTOR,FOREIGN,HEALTH PR
Date Received2020-02-10
Date of Report2020-01-17
Date of Event2020-01-10
Report Date2005-01-01
Date Reported to FDA2005-01-01
Date Reported to Mfgr2005-01-10
Date Mfgr Received2020-01-17
Date Added to Maude2020-02-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. BARBARA CREEL
Manufacturer Street9965 FEDERAL DRIVE
Manufacturer CityCOLORADO SPRINGS CO 80921
Manufacturer CountryUS
Manufacturer Postal80921
Manufacturer Phone719447-246
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameSPECTRANETICS LEAD LOCKING DEVICE
Generic NameLLD
Product CodeDRB
Date Received2020-02-10
Model Number518-062
Catalog Number518-062
Lot NumberUNAVAILABLE FROM FACILITY
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Sequence No1
Device Event Key0
ManufacturerTHE SPECTRANETICS CORPORATION
Manufacturer Address9965 FEDERAL DRIVE COLORADO SPRINGS CO 80921 US 80921

Device Sequence Number: 101

Product Code---
Date Received2020-02-10
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention 2020-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.